Appili Therapeutics Inc. (TSX: APLI)
Canada
· Delayed Price · Currency is CAD 0.0350
0.00 (0.00%)
Jul 18, 2024, 2:59 PM EDT
Appili Therapeutics Cash Flow Statement
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Year Ending | TTM | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
| Net Income | -3.78 | -3.78 | -9.24 | -25.12 | -14.33 | -5.42 | Upgrade
|
| Depreciation & Amortization | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | Upgrade
|
| Depreciation & Amortization, Total | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0 | -0 | 0.02 | 0 | 0 | - | Upgrade
|
| Stock-Based Compensation | 0.19 | 0.19 | 0.88 | 2.04 | 1.17 | 0.6 | Upgrade
|
| Other Operating Activities | 0.45 | 0.45 | 1.47 | 1.5 | 0.04 | 0.03 | Upgrade
|
| Change in Accounts Receivable | -1.04 | -1.04 | 0.35 | 0.57 | -0.86 | 0.15 | Upgrade
|
| Change in Inventory | - | - | - | - | 0.04 | 0.07 | Upgrade
|
| Change in Accounts Payable | 1.38 | 1.38 | -4.16 | 1.92 | 3.21 | 0.02 | Upgrade
|
| Change in Other Net Operating Assets | 0.04 | 0.04 | -0.05 | 0.27 | -0.23 | 0.06 | Upgrade
|
| Operating Cash Flow | -2.46 | -2.46 | -10.1 | -19.08 | -11.45 | -4.26 | Upgrade
|
| Capital Expenditures | -0.03 | -0.03 | -0 | - | -0.01 | -0 | Upgrade
|
| Sale of Property, Plant & Equipment | 0 | 0 | - | - | - | - | Upgrade
|
| Investment in Securities | - | - | - | 5.06 | -4.98 | -0 | Upgrade
|
| Investing Cash Flow | -0.03 | -0.03 | -0 | 5.06 | -4.99 | -0 | Upgrade
|
| Long-Term Debt Issued | 0.3 | 0.3 | 2.5 | 8 | - | 0.24 | Upgrade
|
| Total Debt Issued | 0.3 | 0.3 | 2.5 | 8 | - | 0.24 | Upgrade
|
| Long-Term Debt Repaid | -0.1 | -0.1 | -0.09 | -4.17 | -0.02 | -0.05 | Upgrade
|
| Total Debt Repaid | -0.1 | -0.1 | -0.09 | -4.17 | -0.02 | -0.05 | Upgrade
|
| Net Debt Issued (Repaid) | 0.2 | 0.2 | 2.41 | 3.83 | -0.02 | 0.19 | Upgrade
|
| Issuance of Common Stock | - | - | 3.21 | 5.39 | 14.56 | 7.99 | Upgrade
|
| Other Financing Activities | -0.08 | -0.08 | 0.28 | 0.35 | 2.47 | 1.18 | Upgrade
|
| Financing Cash Flow | 0.12 | 0.12 | 5.91 | 9.56 | 17.02 | 9.36 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0 | 0 | -0.01 | 0.06 | -0.02 | -0.01 | Upgrade
|
| Net Cash Flow | -2.37 | -2.37 | -4.2 | -4.4 | 0.55 | 5.09 | Upgrade
|
| Free Cash Flow | -2.49 | -2.49 | -10.1 | -19.08 | -11.46 | -4.26 | Upgrade
|
| Free Cash Flow Margin | -301.44% | -301.44% | -3022.65% | -1372.07% | - | -2140.26% | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.02 | -0.09 | -0.29 | -0.19 | -0.12 | Upgrade
|
| Cash Interest Paid | 1.1 | 1.1 | 0.48 | 0.09 | 0.02 | 0.07 | Upgrade
|
| Cash Income Tax Paid (Refunded) | 0.06 | 0.06 | 0.01 | - | - | - | Upgrade
|
| Levered Free Cash Flow | -5.22 | -5.22 | -7.37 | -11.74 | -7.04 | -2.47 | Upgrade
|
| Unlevered Free Cash Flow | -4.2 | -4.2 | -6.77 | -10.77 | -6.97 | -2.46 | Upgrade
|
| Change in Net Working Capital | -0.65 | -0.65 | 2.79 | -2.6 | -1.64 | -0.76 | Upgrade
|
Source: S&P Capital IQ. Standard template.